<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2022.122013</article-id><article-id pub-id-type="publisher-id">WJCD-115507</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Cardio-Renal Syndrome: Epidemiological Aspect in the Medicine Department of Tombouctou Hospital
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bassirima</surname><given-names>Traore</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samba</surname><given-names>Sidibé</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Souleymane</surname><given-names>Mariko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Karamoko</surname><given-names>Kantako</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Massama</surname><given-names>Konaté</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kalifa</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nouhoum</surname><given-names>Diallo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mariam</surname><given-names>Sako</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoul</surname><given-names>Karim Sacko</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Youssouf</surname><given-names>Kassambara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ichaka</surname><given-names>Menta</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Souleymane</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Cardiology Department of the Point G University Hospital, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Department of Medicine, Tombouctou Hospital, Tombouctou, Mali</addr-line></aff><aff id="aff4"><addr-line>Cardiology Department CHU Gabriel TOURE, Bamako, Mali</addr-line></aff><aff id="aff3"><addr-line>Cardiology Department, Mali Hospital, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>16</day><month>02</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>123</fpage><lpage>132</lpage><history><date date-type="received"><day>9,</day>	<month>January</month>	<year>2022</year></date><date date-type="rev-recd"><day>22,</day>	<month>February</month>	<year>2022</year>	</date><date date-type="accepted"><day>25,</day>	<month>February</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: 
  Cardio-renal syndrome is a pathophysiological disorder of the heart and kidneys in which chronic or acute dysfunction of one can lead to chronic or acute dysfunction of the other. The objective of this study was to determine the prevalence of cardio-renal syndrome in the Medical Department of the Tombouctou Hospital in Mali.
   
  <b>Methods:</b>
  <b> </b>
  It is about a descriptive transversal study carried out over 18 months, from January 01<sup>st</sup>, 2020 to June 30<sup>th</sup>, 2021 and relating to the analysis of 75 files of patients hospitalized for heart failure and with impaired renal function.
   
  <b>Results: </b>
  The frequency of cardio-renal syndrome was 6.4% with a predominance of men (sex ratio: 2). Hypertension was the most widely described risk factor (50.6%). The history was dominated by chronic heart failure (14.6%) and diabetes (6.6%). The average age was 58 with extremes of 18 and 90. The main aetiologies were dilated cardiomyopathy (46.6%) and ischemic heart disease (20%). Symptoms were dominated by dyspnea (90.6%) and edema of the lower limbs and face (74.6%) accompanied by cough (74.6%). Anemia was noted in 15 patients (20%). The mean clearance (MDRD) 
  was 
  at 32 ml/min. Doppler echocardiography found left ventricular dilation (66.6%), lower left ventricular systolic fraction (64%) and kinetic abnormalities (20%). The kidney ultrasound performed in 9 patients returned to normal in 8 cases and in 1 patient the kidneys were small. Eight deaths (10.6%) were noted
  . <b>Conclusion: </b>Cardio-renal syndrome is a common feature in which mixed failure is observed in the unfavorable course of heart disease and nephropathy. Its prevalence is unfortunately under evaluated in cardi
  ological settings in Africa and particularly in Mali, hence the interest of a more advanced study.
 
</p></abstract><kwd-group><kwd>Cardio-Renal Syndrome</kwd><kwd> Epidemiology</kwd><kwd> Tombouctou Hospital</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cardio-renal syndrome is a pathophysiological disorder of the heart and kidneys in which chronic or acute dysfunction of one can lead to chronic or acute dysfunction of the other [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>]. Cardio-renal syndrome is classified by Ronco [<xref ref-type="bibr" rid="scirp.115507-ref2">2</xref>] into five subtypes (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>His diagnosis is made on the basis of a picture of clinical heart failure with impaired renal function.</p><p>According to the US ADHERE registry, at least 65% of patients with a picture of acute heart failure have a creatinine clearance &lt; 60 ml/min [<xref ref-type="bibr" rid="scirp.115507-ref3">3</xref>].</p><p>In Africa, the prevalence of the cardio-renal syndrome is little assessed in cardiology settings; in Senegal, a study conducted in a cardiology department in Dakar found 3.7% [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>].</p><p>In Mali, no study has dealt with this aspect of the cardio-renal syndrome, hence the interest of our study.</p><p>The objective of this work was to determine the hospital prevalence of cardio-renal syndrome in the Medical Department of the Tombouctou Hospital in Mali.</p></sec><sec id="s2"><title>2. Material and Method</title><p>This was a descriptive transversal study carried out in the medical department of the Tombouctou hospital from January 2020 to June 2021, during which we included 75 patients with heart failure associated with impaired renal function.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> RONCO classification of cardio-renal syndrome</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >TYPES</th><th align="center" valign="middle" >CHARACTERISTICS</th></tr></thead><tr><td align="center" valign="middle" >Type 1</td><td align="center" valign="middle" >Acute CRS characterized by acute decompensated heart failure leading to acute renal failure.</td></tr><tr><td align="center" valign="middle" >Type 2</td><td align="center" valign="middle" >Chronic CRS is characterized by chronic heart failure which leads to chronic kidney disease.</td></tr><tr><td align="center" valign="middle" >Type 3</td><td align="center" valign="middle" >Acute reno-cardiac syndrome is due to acute renal failure which leads to acute cardiac dysfunction, such as arrhythmia or heart failure.</td></tr><tr><td align="center" valign="middle" >Type 4</td><td align="center" valign="middle" >Chronic reno-cardiac syndrome is characterized by primary chronic kidney disease that contributes to cardiac dysfunction.</td></tr><tr><td align="center" valign="middle" >Type 5</td><td align="center" valign="middle" >Also called secondary CRS where there is simultaneous renal and cardiac involvement due to systemic disorders such as sepsis or systemic lupus erythematosus.</td></tr></tbody></table></table-wrap><p>CRS: Cardio-renal syndrome.</p><p>The volunteers were patients hospitalized with heart failure and impaired kidney function. After obtaining informed consent, they were included in the study.</p><sec id="s2_1"><title>2.1. Collection of Data</title><p>Data collection was done from hospital records.</p><p>The data collected were socio-demographic, clinical (functional signs, physical signs), cardiovascular and para-clinical risk factors (trans-thoracic echocardiography, renal ultrasound, biological: blood count, glycemia, creatinemia, ionogramblood).</p></sec><sec id="s2_2"><title>2.2. Judging Criteria</title><p>Clinical: patients with symptoms suggestive of heart failure.</p><p>The positive diagnosis of cardio-renal syndrome was based on:</p><p>- a clinical syndrome of heart failure,</p><p>- a serum creatinine greater than 1.4 mg/dl in women and 1.3 mg/dl in men.</p><p>Claudio Ronco’s classification was used in this work.</p></sec><sec id="s2_3"><title>2.3. Operational Definitions</title><p>Cardio-renal syndrome is a pathophysiological disorder of the heart and kidneys in which chronic or acute dysfunction of one can lead to chronic or acute dysfunction of the other.</p><p>Signs of heart failure (HF) were dyspnea (according to NYHA), crackling rales, left galloping noise for left HF and hepatalgia, right galloping noise, hepatomegaly, chest edema, lower limbs, the turgor of the jugular veins for the right CI. Renal impairment was considered for serum creatinine greater than 1.4 mg/dl in women and 1.3 mg/dl in men.</p></sec><sec id="s2_4"><title>2.4. Variables</title><p>Data were collected using the observational medical record and recorded in a questionnaire. This questionnaire was written by the scientific manager and the principal investigator and included.</p><p>The statistical population studied was patients with heart failure and impaired renal function.</p><p>The variables studied were:</p><p>- Quantitative includes the age of the patients, the seniority of hypertension and diabetes, the number of days of hospitalization and of deaths.</p><p>- Qualitative included the sex of the patients, symptoms, description of doppler echocardiographic abnormalities and biology. The questionnaire was submitted to a follow-up test on the recruitment procedure and data analysis.</p><p>The questionnaire was submitted to a daily quality control before being collected.</p><p>Excel 2016 software was used for data collection and then analyzed by SPSS 24 software.</p></sec><sec id="s2_5"><title>2.5. Ethics</title><p>Informed consent was obtained with strict respect for confidentiality.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. The General Characteristics of the Studied Population</title><p>Out of 1165 hospitalized patients, 75 had cardio-renal syndrome, including 25 women. The hospital prevalence was 6.4%. The average age was 58 with extremes of 18 and 90. Chronic heart failure was the most common medical history (14.6%) (<xref ref-type="table" rid="table2">Table 2</xref>). Cardiovascular risk factors were dominated by high blood pressure with 50.6%. The mode of discovery was the table of global heart failure (74.6%). The clinical symptoms were dominated by dyspnea (90.6%) and edema of the lower limbs and face (74.6%) accompanied by cough (74.6%). Anemia was noted in 15 patients (20%). The mean serum creatinine was 3.26 mg/dl. The mean MDRD clearance at 32 ml/min. Regular sinus tachycardia was the dominant abnormality on the EKG (42.6%) followed by left ventricular hypertrophy (34.6%) complete arrhythmia with atrial fibrillation (18.6%). The left ventricular ejection fraction was studied by the teicholz method and there was a dilation of the left ventricle (66.6%) associated with an alteration of the systolic function of the left ventricle (64%). The kidney ultrasound performed in 9 patients returned to normal in 8 cases and in 1 patient the kidneys were small.</p><p>Chronic heart failure dominated the personal medical history (14.6%) of frequency and global heart failure dominated the circumstances of discovery (74.6%).</p></sec><sec id="s3_2"><title>3.2. Etiological Factors of CRS</title><p>The etiologies of cardio-renal syndrome were dilated cardiomyopathy (46.6%), ischemic heart disease (20%), chronic renal failure (8%), hypertrophic cardiomyopathy (2.6%) and diabetes (2.6%) (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>According to Ronco’s classification, cardio-renal syndrome type 1 dominated (72%) followed by type 2 (14.6%) (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients according to personal medical history and the circumstances of discovery</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Personal medical history</th><th align="center" valign="middle" >Effectives</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Chronic heart failure</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >14.6</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >6.6</td></tr><tr><td align="center" valign="middle" >Chronic renal failure</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >HIV</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3</td></tr><tr><td align="center" valign="middle" >Circumstances of discovery</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Global heart failure</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >74.6</td></tr><tr><td align="center" valign="middle" >Left ventricular failure</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >9</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of patients according to etiological factors</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiology</th><th align="center" valign="middle" >Effectives</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Dilated cardiomyopathy</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >46.6</td></tr><tr><td align="center" valign="middle" >Ischemic heart disease</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Chronic renal failure</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Hypertrophic cardiomyopathy</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >13.3</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients according to the RONCO classification of cardio-renal syndrome</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Classification</th><th align="center" valign="middle" >Effectives</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Type 1</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >72</td></tr><tr><td align="center" valign="middle" >Type 2</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >14.7</td></tr><tr><td align="center" valign="middle" >Type 3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >5.3</td></tr><tr><td align="center" valign="middle" >Type 4</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Type 5</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>Dilated cardiomyopathy and ischemic heart disease dominated the etiologies with 46.6% and 20% frequency, respectively.</p><p>It was dominated by type 1,i.e. (72%).</p></sec><sec id="s3_3"><title>3.3. The Treatment</title><p>All the patients benefited from treatment with a diuretic and a sodium-reduced diet. ACE inhibitors were prescribed in 69.3% (52 patients), beta blockers in 18 patients (24%) and calcium channel blockers in 16% (12 patients).</p></sec><sec id="s3_4"><title>3.4. Hospital Evolution</title><p>The duration of hospitalization was 5.4 days. The outcome was favorable in the majority of cases (72%). Complications included 20% refractory heart failure, 8% dialysis and 2.6% cerebral embolism (2 cases). We recorded 8 deaths,i.e. 10.6% lethality. These were refractory heart failure (20%) and stroke (6.6%) <xref ref-type="table" rid="table5">Table 5</xref>.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The prevalence of cardio-renal syndrome in our series is of the order of 6.4% higher than the 3.7% of the Dakar study [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>] and lower than 65% according to the American ADHERE registry [<xref ref-type="bibr" rid="scirp.115507-ref3">3</xref>] be explained by the financial and security difficulties preventing patients not residing in the city of Tombouctou to consult.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of patients according to the type of complication under treatment</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Complication</th><th align="center" valign="middle" >Effectives</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Refractory heart failure</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >ACFA</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >18.6</td></tr><tr><td align="center" valign="middle" >Death</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >10.6</td></tr><tr><td align="center" valign="middle" >Chronic Renal Insufficiency with dialysis</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Intracavitary thrombus</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >6.6</td></tr></tbody></table></table-wrap><p>The average age was 58 years, higher than the 57.26 &#177; 16.04 years of kingue [<xref ref-type="bibr" rid="scirp.115507-ref4">4</xref>], but which remains relatively young by agreement in most African studies carried out on heart failure. Unlike in the West, this is a pathology in the subject aged around 70 years [<xref ref-type="bibr" rid="scirp.115507-ref5">5</xref>], this difference is explained by the early management of heart disease and nephropathy as well as risk factors in the West.</p><p>The male sex predominated (sex ratio at 2) in phage with Kingue (sex ratio at 1.3) and Bodian (sex ratio at 1.7) unlike Go which had a female predominance at 55% [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref5">5</xref>]. Arterial hypertension was the most described risk factor 50.6% in line with Lanzy [<xref ref-type="bibr" rid="scirp.115507-ref6">6</xref>] and most of the African but also African-American studies on heart failure [<xref ref-type="bibr" rid="scirp.115507-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref11">11</xref>]. The history was chronic heart failure of hypertensive origin 14.6% and diabetes 6.6% according to Bodian and Sarra [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref12">12</xref>].</p><p>The etiological factors of CRS are dominated by hypertensive dilated cardiomyopathy (46.6%) and ischemic heart disease (20%) in agreement with Bodian [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>] and the rest of the literature.</p><p>In the majority of cases (72%), the SCR was type 1 versus (97.22%) for type 2 in Bodian [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>], our study was carried out in a medical department where all the other medical specialties were there.</p><p>In our series, the picture of global heart failure (74.6%) was the most common discovery method, consistent with the rest of the literature [<xref ref-type="bibr" rid="scirp.115507-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref15">15</xref>] explaining the severity of cardio-renal syndrome. Renal damage was biologically constant with a mean creatinine clearance of 32 ml/min. Doppler echocardiography noted dilation of the left ventricle associated with impaired systolic function 64% compared to 71% in Bodian [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>].</p><p>This difference can be explained by the fact that our study took place in a medical service against the Dakar series in the cardiology service. We recorded a low case fatality rate of 10.6% compared to most of the literature due to the small sample size [<xref ref-type="bibr" rid="scirp.115507-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.115507-ref17">17</xref>].</p><p>The limitations of our study:</p><p>The small size of our sample; financial difficulties and the security situation linked to the rebellion in the area prevented patients from being consulted at the hospital.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Cardio-renal syndrome is a common feature in which mixed failure is observed in the unfavorable course of heart disease and nephropathy. Its prevalence is unfortunately underestimated in cardiological settings in Africa and in particular in Mali, hence the interest of a more advanced study.</p></sec><sec id="s6"><title>Recommendations</title><p>We focus on raising public awareness and health workers on the regular and correct monitoring of high blood pressure.</p><p>At the level of political decision-makers: Reinforce accessibility to care.</p><p>Research: We believe that prospective and multicentre studies are necessary to better determine the prevalence of CRS in Africa and in Mali in particular.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We thank the management of the Tombouctou Hospital for completing the administrative and regulatory formalities for this work, as well as the patients for their trust.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Traore, B., Sidib&#233;, S., Mariko, S., Kantako, K., Konat&#233;, M., Diallo, K., Diallo, N., Sako, M., Sacko, A.K., Kassambara, Y., Menta, I. and Coulibaly, S. (2022) Cardio-Renal Syndrome: Epidemiolo- gical Aspect in the Medicine Department of Tombouctou Hospital. World Journal of Cardiovascular Diseases, 12, 123-132. https://doi.org/10.4236/wjcd.2022.122013</p></sec><sec id="s10"><title>Survey Sheet No.……</title><sec id="s10_1"><title>1. Socio-Demographic Data</title><p>Last name:………………….First name:………………………….Sex:……….</p><p>Profession:………………… Residence:…………….......…….Age:…………</p></sec><sec id="s10_2"><title>2. Reason and Date of Hospitalization</title><p>1) pattern:</p><p>2) Date: 3) Duration:</p></sec><sec id="s10_3"><title>3. Personal Background</title><p>a) hypertension d) Diabetes</p><p>b) chronic kidney failure f) Heart valve disease</p><p>c) Heart failure g) others:</p></sec><sec id="s10_4"><title>4. Cardiovascular Risk Factors</title><p>1) Hypertension 4) Age &gt; 60 ans</p><p>2) Smoking 5) Obesity</p><p>3) Dyslipidemia 6) Famaly history of myocardial infarction</p></sec><sec id="s10_5"><title>5. Physical Examination</title><p>1) General examination</p><p>a) Signsof congestions b) others:</p><p>2) Cardiac Examination:</p></sec><sec id="s10_6"><title>6. Futher Examination</title><p>1) EKG:</p><p>a) Heart rate: c) Hypertrophies</p><p>b) Conduction desorders d) Evidence of ischemia</p><p>2) Ultrasonic cardiography</p><p>a) kinematic: c) Sidewalls:</p><p>b) EF: d) P&#233;ricardite</p><p>3) Biology</p><p>a) Blood count formula: b) Urea:</p><p>b) Glycemia: d) Creatininemia:</p><p>4) Kidney ultrasound:</p><p>a) Standard: b) others:</p></sec><sec id="s10_7"><title>7. Diagnostic</title><p>1) CRS Type</p><p>a) I c) III e) V</p><p>b) II d) IV</p><p>2) Cardiomyopathies:</p><p>3) Kidney failure:</p><p>4) others:</p></sec><sec id="s10_8"><title>8. Evolution</title><p>1) Favorable 2) Death 3) Refer</p></sec></sec></body><back><ref-list><title>References</title><ref id="scirp.115507-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bodian, M., Thiaw, A., Sarr, S.A., Babaka, K., Aw, F., Ngaide, A.A., Ndiaye, M.B., Kane, A., Jobe, M., Mbaye, A., Diao, M., Sarr, M. and Ba, S.A. (2017) Epidemiological Features of Cardiorenal Syndrome: A Study of 36 Cases in the Cardiology Department in Dakar. The Pan African Medical Journal, 28, 58.  
https://doi.org/10.11604/pamj.2017.28.58.10257</mixed-citation></ref><ref id="scirp.115507-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ronco, C., Kaushik, M., Valle, R., Aspromonte, N. and Peacock, W.F. (2012) Diagnosis and Management of Fluid Overload in Heart Failure and Cardiorenal Syndrome: The “5B” Approach. Seminars in Nephrology, 32, 129-141.  
https://doi.org/10.1016/j.semnephrol.2011.11.016</mixed-citation></ref><ref id="scirp.115507-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Heywood, J.T., Fonarow, G.C., Costanzo, M.R., Mathur, V.S., Wigneswaran, J.R., Wynne, J., et al. (2007) High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized with Acute Decompensated Heart Failure: A Report from the ADHERE Database. Journal of Cardiac Failure, 13, 422-430.  
https://doi.org/10.1016/j.cardfail.2007.03.011</mixed-citation></ref><ref id="scirp.115507-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kingue, S., Dzudie, A., Menanga, A., Akono, M., Ouankou, M. and Muna, W. (2005) New Look at Chronic Heart Failure in Adults in Africa in the Era of Doppler Echocardiography: Experience of the Medical Department of the Yaoundé General Hospital. Ann Cardiol Angeiol (Paris), 54, 276-283.</mixed-citation></ref><ref id="scirp.115507-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E. and Hsu, C. (2004) Chronic Kidney Disease and the Risks of Death, Cardiovascular Events and Hospitalization. The New England Journal of Medicine, 351, 1296-1305.  
https://doi.org/10.1056/NEJMoa041031</mixed-citation></ref><ref id="scirp.115507-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lanzy, A., Voumbo Matoumona, Y.V.Y., Ondziel Opara, A.S., Niama, A.C., Banga Mouss, R.B., Ondongo Atipo, A.M., Dimi Nianga, Y., Odzébé, A.W.S. and Bouya, P.A. (2021) Epidemiology and Etiologies of Acute Obstructive Renal Failure at the University Teaching Hospital of Brazzaville. Health Sciences and Disease, 22, 98-102.</mixed-citation></ref><ref id="scirp.115507-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bivigou, E.A., Allognon, M.C., Ndoume, F., Mipinda, J.B. and Nzengue, E.E. (2018) Mortality Rate in Patients with Heart Failure at the Libreville University Hospital and Associated Factors. Pan African Medical Journal, 31, 27.  
https://doi.org/10.11604/pamj.2018.31.27.13259</mixed-citation></ref><ref id="scirp.115507-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Damasceno, A., Mayosi, B.M. and Sani, M. (2012) The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans from 9 Countries. Archives of Internal Medicine, 172, 1386-1394. https://doi.org/10.1001/archinternmed.2012.3310</mixed-citation></ref><ref id="scirp.115507-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Karaye, K.M. and Sani, M.U. (2008) Factors Associated with Poor Prognosis among Patients Admitted with Heart Failure in a Nigerian Tertiary Medical Centre: A Cross-Sectional Study. BMC Cardiovascular Disorders, 8, Article No. 16.  
https://doi.org/10.1186/1471-2261-8-16</mixed-citation></ref><ref id="scirp.115507-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Makubi, A., Hage, C., Lwakatare, J., et al. (2014) Contemporary Aetiology, Clinical Characteristics and Prognosis of Adults with Heart Failure Observed in a Tertiary Hospital in Tanzania: The Prospective Tanzania Heart Failure (TaHeF) Study. Heart, 100, 1235-1241. https://doi.org/10.1136/heartjnl-2014-305599</mixed-citation></ref><ref id="scirp.115507-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thiam</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Heart Failure in an African Cardiological Environment</article-title><source> Bulletin de la Société de Pathologie Exotique</source><volume> 96</volume>,<fpage> 217</fpage>-<lpage>218</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.115507-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Jouini, S., Manai, H., Slimani, O., Hedhli, H., Hebaieb, F., Mezghanni, M., Aloui, A. and Kaddour, R.B. (2019) Epidemiological and Prognostic Profile of Acute Heart Failure: Experience in the Emergency Department at the Charles Nicole Hospital of Tunis from 2013 to 2014. The Pan African Medical Journal, 33, 251.  
https://doi.org/10.11604/pamj.2019.33.251.17207</mixed-citation></ref><ref id="scirp.115507-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Adams, K.F., Fonarow, G.C., Emerman, C.L., LeJemtel, T.H., Costanzo, M.R., Abraham, W.T., et al. (2005) Characteristics and Outcomes of Patients Hospitalized for Heart Failure in the United States: Rationale, Design, and Preliminary Observations from the First 100,000 Cases in the Acute Decompensated Heart Failure National Registry (ADHERE). American Heart Journal, 149, 209-216.  
https://doi.org/10.1016/j.ahj.2004.08.005</mixed-citation></ref><ref id="scirp.115507-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Gheorghiade, M., Abraham, W.T., Albert, N.M., Greenberg, B.H., O’Connor, C.M., She, L., et al. (2006) Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized with Acute Heart Failure. JAMA, 296, 2217-2226. https://doi.org/10.1001/jama.296.18.2217</mixed-citation></ref><ref id="scirp.115507-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Nieminen, M.S., Brutsaert, D., Dickstein, K., Drexler, H., Follath, F., Harjola, V.-P., et al. (2006) EuroHeart Failure Survey II (EHFS II): A Survey on Hospitalized Acute Heart Failure Patients: Description of Population. European Heart Journal, 27, 2725. https://doi.org/10.1093/eurheartj/ehl193</mixed-citation></ref><ref id="scirp.115507-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Mahon, N.G., Blackstone, E.H., Francis, G.S., Starling, R.C., Young, J.B., Lauer, M.S., et al. (2002) The Prognostic Value of Estimated Creatinine Clearance Alongside Functional Capacity in Ambulatory Patients with Chronic Congestive Heart Failure. Journal of the American College of Cardiology, 40, 1106-1113.  
https://doi.org/10.1016/S0735-1097(02)02125-3</mixed-citation></ref><ref id="scirp.115507-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Yancy, C.W., Lopatin, M., Stevenson, L.W., De Marco, T. and Fonarow, G.C. (2006) Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted with Acute Decompensated Heart Failure with Preserved Systolic Function: A Report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. Journal of the American College of Cardiology, 47, 76-84.  
https://doi.org/10.1016/j.jacc.2005.09.022</mixed-citation></ref></ref-list></back></article>